alexa Editor - MAYUR A. GADHIKAR | The University of Texas MD Anderson | 23036

Journal of Molecular Histology & Medical Physiology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Recommended Conferences

MAYUR A. GADHIKAR

MAYUR A. GADHIKAR
Mayur A. Gadhikar
Post-Doctoral Fellow
Department of Head and Neck Surgery
University of Texas
US

Biography

Mayur Gadhikar received his B.Tech in Pharmaceuticals and Fine chemicals in 2006 from University Institute of Chemical Technology, Mumbai. He completed masters in biotechnology in 2007 and also earned certification in business from Mays Business School at Texas A&M University, College Station. In 2009, after working for about year and half at an oncology research consultancy, he joined a PhD program in Cancer Biology at MD Anderson Cancer Center, Houston. In his thesis work, Mayur Gadhikar, investigated the therapeutic targeting of checkpoint kinases in head and neck cancer, and showed that targeting checkpoint kinases greatly improved the efficacy of mainstay chemotherapy in HNSCC cells. Currently, as a research fellow in the head and neck surgery department, he is doggedly pursuing his investigation of checkpoint kinase inhibitors as monotherapy in HNSCC. In addition, he is also involved in evaluating novel cancer genes in HNSCC.

Research Interest

Cell Cycle, Replication, DNA Repair, Cell Signaling, Targeted therapies, Mechanisms of Action, Mechanism of Cell Death

Relevant Conferences
Leave Your Message 24x7
Top